Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2014 1
2017 1
2019 4
2020 3
2021 2
2022 2
2023 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis.
Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Zamorano L, Oliver A; GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group. Sastre-Femenia MÀ, et al. Lancet Reg Health Eur. 2023 Sep 19;34:100736. doi: 10.1016/j.lanepe.2023.100736. eCollection 2023 Nov. Lancet Reg Health Eur. 2023. PMID: 37753216 Free PMC article.
Spanish nationwide survey of Pseudomonas aeruginosa cefiderocol susceptibility and resistance mechanisms.
Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Oliver A; GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group. Sastre-Femenia MÀ, et al. Int J Antimicrob Agents. 2025 Oct;66(4):107563. doi: 10.1016/j.ijantimicag.2025.107563. Epub 2025 Jul 1. Int J Antimicrob Agents. 2025. PMID: 40609707
Sample pooling for SARS-CoV-2 RT-PCR screening.
de Salazar A, Aguilera A, Trastoy R, Fuentes A, Alados JC, Causse M, Galán JC, Moreno A, Trigo M, Pérez-Ruiz M, Roldán C, Pena MJ, Bernal S, Serrano-Conde E, Barbeito G, Torres E, Riazzo C, Cortes-Cuevas JL, Chueca N, Coira A, Sanchez-Calvo JM, Marfil E, Becerra F, Gude MJ, Pallarés Á, Pérez Del Molino ML, García F. de Salazar A, et al. Among authors: barbeito g. Clin Microbiol Infect. 2020 Dec;26(12):1687.e1-1687.e5. doi: 10.1016/j.cmi.2020.09.008. Epub 2020 Sep 10. Clin Microbiol Infect. 2020. PMID: 32919074 Free PMC article.
Risk Factors of Mortality in Hospitalized Patients With COVID-19 Applying a Machine Learning Algorithm.
Nieto-Codesido I, Calvo-Alvarez U, Diego C, Hammouri Z, Mallah N, Ginzo-Villamayor MJ, Salgado FJ, Carreira JM, Rábade C, Barbeito G, Gonzalez-Perez MÁ, Gonzalez-Barcala FJ. Nieto-Codesido I, et al. Among authors: barbeito g. Open Respir Arch. 2022 Feb 6;4(2):100162. doi: 10.1016/j.opresp.2022.100162. eCollection 2022 Apr-Jun. Open Respir Arch. 2022. PMID: 37497317 Free PMC article.
Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and Isogenic β-Lactam-Resistant Mutants.
Fraile-Ribot PA, Zamorano L, Orellana R, Del Barrio-Tofiño E, Sánchez-Diener I, Cortes-Lara S, López-Causapé C, Cabot G, Bou G, Martínez-Martínez L, Oliver A; GEMARA-SEIMC/REIPI Pseudomonas Study Group. Fraile-Ribot PA, et al. Antimicrob Agents Chemother. 2020 Jan 27;64(2):e02165-19. doi: 10.1128/AAC.02165-19. Print 2020 Jan 27. Antimicrob Agents Chemother. 2020. PMID: 31740559 Free PMC article.
16 results